News
Glioblastoma Drug Development Summit Boston 2025
PMB researchers shared results of pre-clinical evaluations of Immune-12 with industry and academia at the GBM Drug Development Summit. Immune-12 shows promising antitumor effects in various cancers, with ongoing pre-clinical evaluations at the University of North Carolina.
The study aims to evaluate the antitumor potency, characterize the makeup, and determine the mechanisms of Immune-12.
USA Clinical Trials
We recently updated our milestone timeline for US based clinical trials which will be done in association with our ongoing FDA reviews and approvals.
Sea Cucumber – Black Teatfish
The Black Teatfish (Holothuria nobilis) which makes up about 45% of Immune12 is a species of sea cucumber known for its nutritional and medicinal properties. Here are some
Sea Cucumber – Sandfish
The Sea Cucumber Sandfish (Holothuria scabra) which makes up about 40% of Immune12 , has been studied for its potential health benefits, particularly in traditional medicine and
Sea Squirt
Sea squirts (S. clava) which makes up about 5% of Immune 12 have been studied for their potential health benefits, particularly due to their plasmalogen content,
Sea Urchin
Sea Urchins (H. Erythrogramma) make up about 5% of Immune12. Sea urchins in general, including H. erythrogramma, can offer several health benefits when consumed: Rich in